Status:
COMPLETED
Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis
Lead Sponsor:
Liaquat University of Medical & Health Sciences
Collaborating Sponsors:
Università degli Studi dell'Insubria
Conditions:
Chronic Rhinosinusitis Without Nasal Polyps
Chronic Rhinosinusitis (Diagnosis)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized, double-blind, placebo-controlled clinical trial evaluated the safety and efficacy of nasal drops containing Pistacia lentiscus oil in preventing recurrence of chronic rhinosinusitis. ...
Detailed Description
Chronic rhinosinusitis (CRS) is a common and recurrent condition associated with significant morbidity and impaired quality of life. Standard treatment approaches often provide only partial or tempora...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Clinical diagnosis of chronic rhinosinusitis
- Nasal polypoid score ≤1
- ≥4 episodes of recurrence per year
- SNOT-22 score ≥10 Willingness and ability to provide written informed consent
Exclusion
- Nasal polypoid score \>2
- \<4 episodes of recurrence per year
- SNOT-22 score \<10
- Known immune disorders
- Neoplastic disorders
- Neurological disorders
- Psychiatric disorders
- Inability to undergo treatment
- Refusal or inability to provide informed consent
Key Trial Info
Start Date :
January 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07198607
Start Date
January 9 2023
End Date
August 30 2025
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ent Clinic ASST Settelaghi, University of Insubriae
Varese, Italy